Despite the recommendation of two expert committees to ban fixed dose combinations, the issue remains unresolved. Manufacturers of banned FDCs have approached Delhi High Court and sought to question the rationale of the ban on tendentious grounds. This also raises questions over the extent of judicial involvement in deciding upon the content of scientific matters.
EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.
Comments
EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.